• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

初诊慢性淋巴细胞增殖性疾病患者胸部计算机断层扫描的影像学表现

Radiological Findings on Chest Computed Tomography in Patients With the Primary Diagnosed Chronic Lymphoproliferative Diseases.

作者信息

Usenko Ganna, Gashynova Kateryna

机构信息

City Hematology Center, Public Non-profit Enterprise "City Clinical Hospital #4" of Dnipro City Council, Dnipro, UKR.

Department of Occupational Diseases, Clinical Immunology and Clinical Pharmacology, Dnipro State Medical University, Dnipro, UKR.

出版信息

Cureus. 2022 Mar 7;14(3):e22935. doi: 10.7759/cureus.22935. eCollection 2022 Mar.

DOI:10.7759/cureus.22935
PMID:35399482
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8986505/
Abstract

Introduction The presence of concomitant respiratory pathology complicates the process of treatment and recovery of patients with chronic lymphoproliferative diseases (CLDs). Therefore, the diagnosis of lung injury is an important step in the management of such patients. Objectives The aim of this study was to determine the prevalence, nature, extent, and location of changes diagnosed by high-resolution chest computed tomography (CT) in patients with CLDs at the initial examination. Methods Medical records of inpatients who were hospitalized in 2018-2019 to the City Hematology Center of the Public Non-Profit Enterprise "City Clinical Hospital #4" of Dnipro City Council with a confirmed clinical diagnosis of CLDs were included in the retrospective study. The results of initial high-resolution chest CT were studied and analyzed. Results Out of 1,004 hospitalized patients with confirmed CLDs, 119 patients were primarily diagnosed. Among them, 81 patients underwent chest CT examination (68.1%) before the beginning of specific therapy. The average age was 65 (56;68) years, 46 (56.8%) were men. 23 (28.4%) patients were diagnosed with chronic lymphocytic leukemia, 28 (34.6%) patients with multiple myeloma, 24 (29.6%) patients with lymphoma, and six patients (7.4%) had other CLDs. It was found that both central and peripheral lymphadenopathy had about a third of the studied cohort of patients (33.3 and 29.6%, respectively), and these symptoms dominated in patients with chronic lymphocytic leukemia (43.5 and 50%, respectively), lymphoma (50 and 52.2%, respectively), and other CLDs (45.8 and 16.7%, respectively), in contrast to patients with multiple myeloma (7.1 and 0%, respectively). Lesions of the lung parenchyma were found in 45.7% of the studied cohort and were met more often in patients with multiple myeloma (67.9%). However, when comparing the prevalence of their categories, no statistically significant differences were found. Predictable bone-destructive changes were statistically significantly more common in patients with multiple myeloma than in other groups of patients with CLDs (=0.0003). Conclusions Signs of pulmonary diseases during initial chest CT were found almost in half of the patients with CLDs. It potentially may affect the frequency of treatment complications in such patients. Lymphadenopathy was the most common finding on chest CT, especially in patients with chronic lymphocytic leukemia and lymphoma. And enlarged intrathoracic lymph nodes possibly could lead to pulmonary functions disorders. Among the types of lung parenchyma lesions, pneumofibrosis and foci of consolidation in the lower lung lobes were the most often diagnosed. Chest CT is informative at the stage of the initial examination of patients with CLDs not only for clinical diagnosis but also for the diagnosis of respiratory comorbidities and prediction of the disease outcome and treatment complications.

摘要

引言 合并存在的呼吸系统病变会使慢性淋巴细胞增殖性疾病(CLD)患者的治疗和康复过程变得复杂。因此,肺部损伤的诊断是此类患者管理中的重要一步。

目的 本研究的目的是确定初诊时CLD患者经高分辨率胸部计算机断层扫描(CT)诊断出的病变的患病率、性质、范围和位置。

方法 对2018 - 2019年在第聂伯市议会公共非营利企业“第4市立临床医院”市血液中心住院且临床确诊为CLD的患者的病历进行回顾性研究。研究并分析了初次高分辨率胸部CT的结果。

结果 在1004例确诊为CLD的住院患者中,119例为初诊。其中,81例患者(68.1%)在开始特异性治疗前接受了胸部CT检查。平均年龄为65(56;68)岁,46例(56.8%)为男性。23例(28.4%)患者诊断为慢性淋巴细胞白血病,28例(34.6%)患者诊断为多发性骨髓瘤,24例(29.6%)患者诊断为淋巴瘤,6例(7.4%)患者患有其他CLD。发现中央和外周淋巴结病在约三分之一的研究队列患者中出现(分别为33.3%和29.6%),并且这些症状在慢性淋巴细胞白血病患者中占主导(分别为43.5%和50%)、淋巴瘤患者中(分别为50%和52.2%)以及其他CLD患者中(分别为45.8%和16.7%),与多发性骨髓瘤患者相反(分别为7.1%和0%)。肺实质病变在45.7%的研究队列中被发现,并且在多发性骨髓瘤患者中更常见(67.9%)。然而,比较其类别患病率时,未发现统计学上的显著差异。可预测的骨破坏改变在多发性骨髓瘤患者中比在其他CLD患者组中在统计学上显著更常见(P = 0.0003)。

结论 在几乎一半的CLD患者初诊胸部CT时发现了肺部疾病迹象。这可能会影响此类患者治疗并发症的发生率。淋巴结病是胸部CT上最常见的发现,尤其是在慢性淋巴细胞白血病和淋巴瘤患者中。并且胸腔内肿大的淋巴结可能导致肺功能障碍。在肺实质病变类型中,肺纤维化和下肺叶实变灶是最常被诊断出的。胸部CT在CLD患者初诊阶段不仅对临床诊断有帮助,而且对呼吸合并症的诊断以及疾病结局和治疗并发症的预测也有帮助。

相似文献

1
Radiological Findings on Chest Computed Tomography in Patients With the Primary Diagnosed Chronic Lymphoproliferative Diseases.初诊慢性淋巴细胞增殖性疾病患者胸部计算机断层扫描的影像学表现
Cureus. 2022 Mar 7;14(3):e22935. doi: 10.7759/cureus.22935. eCollection 2022 Mar.
2
Correlations of hematological parameters with bone marrow findings in chronic lymphoproliferative disorders associated with hepatitis viruses.与肝炎病毒相关的慢性淋巴细胞增殖性疾病中血液学参数与骨髓检查结果的相关性
J Med Life. 2013;6(4):464-71. Epub 2013 Dec 25.
3
[Clinical analysis of lymphoma with chest involvement: report of 25 cases].胸部受累淋巴瘤的临床分析:附25例报告
Zhonghua Nei Ke Za Zhi. 2009 Oct;48(10):846-9.
4
Bird fancier's lung: a series of 86 patients.养鸟人肺:86例患者系列研究
Medicine (Baltimore). 2008 Mar;87(2):110-130. doi: 10.1097/MD.0b013e31816d1dda.
5
Intrathoracic lymphadenopathy in hospitalized patients with pneumococcal pneumonia.肺炎球菌肺炎住院患者的胸内淋巴结病
Chest. 2005 Apr;127(4):1271-5. doi: 10.1378/chest.127.4.1271.
6
Differential diagnosis of lymphocytic interstitial pneumonia and malignant lymphoma on high-resolution CT.高分辨率CT对淋巴细胞性间质性肺炎和恶性淋巴瘤的鉴别诊断
AJR Am J Roentgenol. 1999 Jul;173(1):71-4. doi: 10.2214/ajr.173.1.10397102.
7
The effect of direct referral for fast CT scan in early lung cancer detection in general practice. A clinical, cluster-randomised trial.在全科医疗中,直接转诊进行快速CT扫描对早期肺癌检测的效果。一项临床、整群随机试验。
Dan Med J. 2015 Mar;62(3).
8
[A clinical analysis of 40 cases of primary and secondary pulmonary lymphoma].40例原发性和继发性肺淋巴瘤的临床分析
Zhonghua Jie He He Hu Xi Za Zhi. 2014 Jul;37(7):502-6.
9
Cystic lung diseases: radiological aspects.囊性肺疾病:影像学表现。
Clin Radiol. 2022 May;77(5):e337-e345. doi: 10.1016/j.crad.2022.01.044. Epub 2022 Feb 26.
10
Clinical and radiographic predictors of the etiology of computed tomography-diagnosed intrathoracic lymphadenopathy in HIV-infected patients.HIV感染患者计算机断层扫描诊断的胸内淋巴结病病因的临床和影像学预测因素
J Acquir Immune Defic Syndr. 2002 Nov 1;31(3):291-8. doi: 10.1097/00126334-200211010-00004.

本文引用的文献

1
Outcome of a Real-World Patient Cohort with Secondary CNS Lymphoma Treated with High-Intensity Chemoimmunotherapy and Autologous Stem Cell Transplantation.接受高强度化疗免疫疗法和自体干细胞移植治疗的继发性中枢神经系统淋巴瘤真实世界患者队列的结局
Oncol Res Treat. 2021;44(7-8):375-381. doi: 10.1159/000517531. Epub 2021 Jul 21.
2
A high definition picture of somatic mutations in chronic lymphoproliferative disorder of natural killer cells.高清晰度图片展示自然杀伤细胞慢性淋巴增生性疾病中的体细胞突变。
Blood Cancer J. 2020 Apr 22;10(4):42. doi: 10.1038/s41408-020-0309-2.
3
[EFFECTIVENESS AND SAFETY OF METHOTREXATE MONOTHERAPY IN PATIENTS WITH PULMONARY SARCOIDOSIS].[甲氨蝶呤单药治疗结节病患者的有效性和安全性]
Georgian Med News. 2018 Oct(283):34-38.
4
Global Burden of Multiple Myeloma: A Systematic Analysis for the Global Burden of Disease Study 2016.多发性骨髓瘤全球负担:2016 年全球疾病负担研究的系统分析。
JAMA Oncol. 2018 Sep 1;4(9):1221-1227. doi: 10.1001/jamaoncol.2018.2128.
5
Relationship between co-morbidities at diagnosis, survival and ultimate cause of death in patients with chronic lymphocytic leukaemia (CLL): a prospective cohort study.慢性淋巴细胞白血病(CLL)患者诊断时的合并症、生存率与最终死亡原因之间的关系:一项前瞻性队列研究。
Br J Haematol. 2017 Aug;178(3):394-402. doi: 10.1111/bjh.14785. Epub 2017 Jun 4.
6
Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.甲氨蝶呤、阿糖胞苷、噻替派和利妥昔单抗联合化疗免疫疗法(MATRix方案)用于原发性中枢神经系统淋巴瘤患者:国际结外淋巴瘤研究组-32(IELSG32)2期试验首次随机分组结果
Lancet Haematol. 2016 May;3(5):e217-27. doi: 10.1016/S2352-3026(16)00036-3. Epub 2016 Apr 6.
7
Severe and fatal adverse events risk associated with rituximab addition to B-cell non-Hodgkin's lymphoma (B-NHL) chemotherapy: a meta-analysis.在B细胞非霍奇金淋巴瘤(B-NHL)化疗中添加利妥昔单抗相关的严重及致命不良事件风险:一项荟萃分析。
J Chemother. 2015;27(6):365-70. doi: 10.1179/1973947815Y.0000000025. Epub 2015 Apr 15.
8
Cancer statistics, 2010.癌症统计数据,2010 年。
CA Cancer J Clin. 2010 Sep-Oct;60(5):277-300. doi: 10.3322/caac.20073. Epub 2010 Jul 7.